APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drugs of Abuse Testing Systems

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Drugs of Abuse Testing Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 July 2026190 pages

Choose your research edition.

Industry ResearchDrugs of Abuse Testing Systems Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Drugs of Abuse Testing Systems Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Drugs of Abuse Testing Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drugs of Abuse Testing Systems Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Drugs of Abuse Testing Systems Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Drugs of Abuse Testing Systems market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Drugs of Abuse Testing Systems is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drugs of Abuse Testing Systems is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drugs of Abuse Testing Systems is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Drugs of Abuse Testing Systems is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Drugs of Abuse Testing Systems include Abbott, Thermo Fisher Scientific, Roche, Wondfo Biotech, Siemens Healthineers, Randox Laboratories, Orient Gene Biotech, OraSure and Intec, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Drugs of Abuse Testing Systems market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drugs of Abuse Testing Systems and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drugs of Abuse Testing Systems sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Drugs of Abuse Testing Systems market size, projected growth trends, production technologies, key applications, and end-use industries.

Drugs of Abuse Testing Systems Segment by Company

Abbott

Thermo Fisher Scientific

Roche

Wondfo Biotech

Siemens Healthineers

Randox Laboratories

Orient Gene Biotech

OraSure

Intec

Hangzhou Biotest

Drager

Assure Tech (Hangzhou) Co

Aotai Bio

Drugs of Abuse Testing Systems Segment by Type

Urine Screening System

Saliva Test System

Others

Drugs of Abuse Testing Systems Segment by Application

Hospital

Laboratory

Others

Drugs of Abuse Testing Systems Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs of Abuse Testing Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drugs of Abuse Testing Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs of Abuse Testing Systems.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Drugs of Abuse Testing Systems market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Drugs of Abuse Testing Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Drugs of Abuse Testing Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Drugs of Abuse Testing Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Drugs of Abuse Testing Systems Industry Trends Table 2. Drugs of Abuse Testing Systems Industry Drivers Table 3. Drugs of Abuse Testing Systems Industry Opportunities and Challenges Table 4. Drugs of Abuse Testing Systems Industry Restraints Table 5. Global Drugs of Abuse Testing Systems Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Drugs of Abuse Testing Systems Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Drugs of Abuse Testing Systems Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Drugs of Abuse Testing Systems Sales Market Share by Manufacturers Table 9. Global Drugs of Abuse Testing Systems Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Drugs of Abuse Testing Systems Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Drugs of Abuse Testing Systems Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Drugs of Abuse Testing Systems Manufacturers, Product Type & Application Table 13. Global Drugs of Abuse Testing Systems Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Drugs of Abuse Testing Systems by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Urine Screening System Table 17. Major Manufacturers of Saliva Test System Table 18. Major Manufacturers of Others Table 19. Global Drugs of Abuse Testing Systems Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Drugs of Abuse Testing Systems Sales by Type (2021-2026) & (k units) Table 21. Global Drugs of Abuse Testing Systems Sales by Type (2027-2032) & (k units) Table 22. Global Drugs of Abuse Testing Systems Sales Market Share by Type (2021-2026) Table 23. Global Drugs of Abuse Testing Systems Sales Market Share by Type (2027-2032) Table 24. Global Drugs of Abuse Testing Systems Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Drugs of Abuse Testing Systems Revenue by Type (2021-2026) & (k units) Table 26. Global Drugs of Abuse Testing Systems Revenue by Type (2027-2032) & (k units) Table 27. Global Drugs of Abuse Testing Systems Revenue Market Share by Type (2021-2026) Table 28. Global Drugs of Abuse Testing Systems Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Laboratory Table 31. Major Manufacturers of Others Table 32. Global Drugs of Abuse Testing Systems Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Drugs of Abuse Testing Systems Sales by Application (2021-2026) & (k units) Table 34. Global Drugs of Abuse Testing Systems Sales by Application (2027-2032) & (k units) Table 35. Global Drugs of Abuse Testing Systems Sales Market Share by Application (2021-2026) Table 36. Global Drugs of Abuse Testing Systems Sales Market Share by Application (2027-2032) Table 37. Global Drugs of Abuse Testing Systems Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Drugs of Abuse Testing Systems Revenue by Application (2021-2026) & (k units) Table 39. Global Drugs of Abuse Testing Systems Revenue by Application (2027-2032) & (k units) Table 40. Global Drugs of Abuse Testing Systems Revenue Market Share by Application (2021-2026) Table 41. Global Drugs of Abuse Testing Systems Revenue Market Share by Application (2027-2032) Table 42. Global Drugs of Abuse Testing Systems Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Drugs of Abuse Testing Systems Sales by Region (2021-2026) & (k units) Table 44. Global Drugs of Abuse Testing Systems Sales Market Share by Region (2021-2026) Table 45. Global Drugs of Abuse Testing Systems Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Drugs of Abuse Testing Systems Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Drugs of Abuse Testing Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Drugs of Abuse Testing Systems Sales by Country (2021-2026) & (k units) Table 49. North America Drugs of Abuse Testing Systems Sales by Country (2027-2032) & (k units) Table 50. Europe Drugs of Abuse Testing Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Drugs of Abuse Testing Systems Sales by Country (2021-2026) & (k units) Table 52. Europe Drugs of Abuse Testing Systems Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Drugs of Abuse Testing Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Drugs of Abuse Testing Systems Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Drugs of Abuse Testing Systems Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Drugs of Abuse Testing Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Drugs of Abuse Testing Systems Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Drugs of Abuse Testing Systems Sales by Country (2027-2032) & (k units) Table 59. Global Drugs of Abuse Testing Systems Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Drugs of Abuse Testing Systems Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Drugs of Abuse Testing Systems Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Drugs of Abuse Testing Systems Revenue Market Share by Region (2021-2026) Table 63. Global Drugs of Abuse Testing Systems Revenue Market Share by Region (2027-2032) Table 64. Abbott Company Information Table 65. Abbott Business Overview Table 66. Abbott Drugs of Abuse Testing Systems Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Abbott Drugs of Abuse Testing Systems Product Portfolio Table 68. Abbott Recent Development Table 69. Thermo Fisher Scientific Company Information Table 70. Thermo Fisher Scientific Business Overview Table 71. Thermo Fisher Scientific Drugs of Abuse Testing Systems Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Thermo Fisher Scientific Drugs of Abuse Testing Systems Product Portfolio Table 73. Thermo Fisher Scientific Recent Development Table 74. Roche Company Information Table 75. Roche Business Overview Table 76. Roche Drugs of Abuse Testing Systems Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Roche Drugs of Abuse Testing Systems Product Portfolio Table 78. Roche Recent Development Table 79. Wondfo Biotech Company Information Table 80. Wondfo Biotech Business Overview Table 81. Wondfo Biotech Drugs of Abuse Testing Systems Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Wondfo Biotech Drugs of Abuse Testing Systems Product Portfolio Table 83. Wondfo Biotech Recent Development Table 84. Siemens Healthineers Company Information Table 85. Siemens Healthineers Business Overview Table 86. Siemens Healthineers Drugs of Abuse Testing Systems Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Siemens Healthineers Drugs of Abuse Testing Systems Product Portfolio Table 88. Siemens Healthineers Recent Development Table 89. Randox Laboratories Company Information Table 90. Randox Laboratories Business Overview Table 91. Randox Laboratories Drugs of Abuse Testing Systems Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Randox Laboratories Drugs of Abuse Testing Systems Product Portfolio Table 93. Randox Laboratories Recent Development Table 94. Orient Gene Biotech Company Information Table 95. Orient Gene Biotech Business Overview Table 96. Orient Gene Biotech Drugs of Abuse Testing Systems Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Orient Gene Biotech Drugs of Abuse Testing Systems Product Portfolio Table 98. Orient Gene Biotech Recent Development Table 99. OraSure Company Information Table 100. OraSure Business Overview Table 101. OraSure Drugs of Abuse Testing Systems Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. OraSure Drugs of Abuse Testing Systems Product Portfolio Table 103. OraSure Recent Development Table 104. Intec Company Information Table 105. Intec Business Overview Table 106. Intec Drugs of Abuse Testing Systems Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Intec Drugs of Abuse Testing Systems Product Portfolio Table 108. Intec Recent Development Table 109. Hangzhou Biotest Company Information Table 110. Hangzhou Biotest Business Overview Table 111. Hangzhou Biotest Drugs of Abuse Testing Systems Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Hangzhou Biotest Drugs of Abuse Testing Systems Product Portfolio Table 113. Hangzhou Biotest Recent Development Table 114. Drager Company Information Table 115. Drager Business Overview Table 116. Drager Drugs of Abuse Testing Systems Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Drager Drugs of Abuse Testing Systems Product Portfolio Table 118. Drager Recent Development Table 119. Assure Tech (Hangzhou) Co Company Information Table 120. Assure Tech (Hangzhou) Co Business Overview Table 121. Assure Tech (Hangzhou) Co Drugs of Abuse Testing Systems Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Assure Tech (Hangzhou) Co Drugs of Abuse Testing Systems Product Portfolio Table 123. Assure Tech (Hangzhou) Co Recent Development Table 124. Aotai Bio Company Information Table 125. Aotai Bio Business Overview Table 126. Aotai Bio Drugs of Abuse Testing Systems Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Aotai Bio Drugs of Abuse Testing Systems Product Portfolio Table 128. Aotai Bio Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Drugs of Abuse Testing Systems Distributors List Table 132. Drugs of Abuse Testing Systems Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Drugs of Abuse Testing Systems Product Image Figure 2. Global Drugs of Abuse Testing Systems Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drugs of Abuse Testing Systems Market Size (2021-2032) & (US$ Million) Figure 4. Global Drugs of Abuse Testing Systems Sales (2021-2032) & (k units) Figure 5. Global Drugs of Abuse Testing Systems Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Drugs of Abuse Testing Systems Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Urine Screening System Image Figure 9. Saliva Test System Image Figure 10. Others Image Figure 11. Global Drugs of Abuse Testing Systems Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Drugs of Abuse Testing Systems Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Drugs of Abuse Testing Systems Sales Market Share by Type (2021-2032) Figure 14. Global Drugs of Abuse Testing Systems Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Drugs of Abuse Testing Systems Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Drugs of Abuse Testing Systems Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Laboratory Image Figure 19. Others Image Figure 20. Global Drugs of Abuse Testing Systems Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Drugs of Abuse Testing Systems Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Drugs of Abuse Testing Systems Sales Market Share by Application (2021-2032) Figure 23. Global Drugs of Abuse Testing Systems Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Drugs of Abuse Testing Systems Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Drugs of Abuse Testing Systems Revenue Market Share by Application (2021-2032) Figure 26. North America Drugs of Abuse Testing Systems Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Drugs of Abuse Testing Systems Sales Market Share by Country (2021-2032) Figure 28. U.S. Drugs of Abuse Testing Systems Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Drugs of Abuse Testing Systems Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Drugs of Abuse Testing Systems Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Drugs of Abuse Testing Systems Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Drugs of Abuse Testing Systems Sales Market Share by Country (2021-2032) Figure 33. Germany Drugs of Abuse Testing Systems Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Drugs of Abuse Testing Systems Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Drugs of Abuse Testing Systems Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Drugs of Abuse Testing Systems Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Drugs of Abuse Testing Systems Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Drugs of Abuse Testing Systems Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Drugs of Abuse Testing Systems Sales Market Share by Country (2021-2032) Figure 40. China Drugs of Abuse Testing Systems Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Drugs of Abuse Testing Systems Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Drugs of Abuse Testing Systems Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Drugs of Abuse Testing Systems Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Drugs of Abuse Testing Systems Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Drugs of Abuse Testing Systems Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Drugs of Abuse Testing Systems Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Drugs of Abuse Testing Systems Sales Market Share by Country (2021-2032) Figure 48. Brazil Drugs of Abuse Testing Systems Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Drugs of Abuse Testing Systems Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Drugs of Abuse Testing Systems Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Drugs of Abuse Testing Systems Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Drugs of Abuse Testing Systems Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Drugs of Abuse Testing Systems Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Drugs of Abuse Testing Systems Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Drugs of Abuse Testing Systems Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Drugs of Abuse Testing Systems Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Drugs of Abuse Testing Systems Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Drugs of Abuse Testing Systems Revenue (2021-2032) & (US$ Million) Figure 59. North America Drugs of Abuse Testing Systems Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Drugs of Abuse Testing Systems Revenue (2021-2032) & (US$ Million) Figure 61. Europe Drugs of Abuse Testing Systems Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Drugs of Abuse Testing Systems Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Drugs of Abuse Testing Systems Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Drugs of Abuse Testing Systems Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Drugs of Abuse Testing Systems Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Drugs of Abuse Testing Systems Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Drugs of Abuse Testing Systems Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Urine Screening System
  • Saliva Test System
  • Others
Applications
  • Hospital
  • Laboratory
  • Others
Companies covered
  • Abbott
  • Thermo Fisher Scientific
  • Roche
  • Wondfo Biotech
  • Siemens Healthineers
  • Randox Laboratories
  • Orient Gene Biotech
  • OraSure
  • Intec
  • Hangzhou Biotest
  • Drager
  • Assure Tech (Hangzhou) Co
  • Aotai Bio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Drugs of Abuse Testing Systems Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Drugs of Abuse Testing Systems Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Drugs of Abuse Testing Systems Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Drugs of Abuse Testing Systems Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Drugs of Abuse Testing Systems Market Dynamics
  1. 2.1 Drugs of Abuse Testing Systems Industry Trends
  2. 2.2 Drugs of Abuse Testing Systems Industry Drivers
  3. 2.3 Drugs of Abuse Testing Systems Industry Opportunities and Challenges
  4. 2.4 Drugs of Abuse Testing Systems Industry Restraints
3 Drugs of Abuse Testing Systems Market by Manufacturers
  1. 3.1 Global Drugs of Abuse Testing Systems Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Drugs of Abuse Testing Systems Sales by Manufacturers (2021-2026)
  3. 3.3 Global Drugs of Abuse Testing Systems Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Drugs of Abuse Testing Systems Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Drugs of Abuse Testing Systems Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Drugs of Abuse Testing Systems Manufacturers, Product Type & Application
  7. 3.7 Global Drugs of Abuse Testing Systems Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Drugs of Abuse Testing Systems Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Drugs of Abuse Testing Systems Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Drugs of Abuse Testing Systems Tier 1, Tier 2, and Tier 3
4 Drugs of Abuse Testing Systems Market by Type
  1. 4.1 Drugs of Abuse Testing Systems Type Introduction
  2. 4.1.1 Urine Screening System
  3. 4.1.2 Saliva Test System
  4. 4.1.3 Others
  5. 4.2 Global Drugs of Abuse Testing Systems Sales by Type
  6. 4.2.1 Global Drugs of Abuse Testing Systems Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Drugs of Abuse Testing Systems Sales by Type (2021-2032)
  8. 4.2.3 Global Drugs of Abuse Testing Systems Sales Market Share by Type (2021-2032)
  9. 4.3 Global Drugs of Abuse Testing Systems Revenue by Type
  10. 4.3.1 Global Drugs of Abuse Testing Systems Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Drugs of Abuse Testing Systems Revenue by Type (2021-2032)
  12. 4.3.3 Global Drugs of Abuse Testing Systems Revenue Market Share by Type (2021-2032)
5 Drugs of Abuse Testing Systems Market by Application
  1. 5.1 Drugs of Abuse Testing Systems Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Laboratory
  4. 5.1.3 Others
  5. 5.2 Global Drugs of Abuse Testing Systems Sales by Application
  6. 5.2.1 Global Drugs of Abuse Testing Systems Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Drugs of Abuse Testing Systems Sales by Application (2021-2032)
  8. 5.2.3 Global Drugs of Abuse Testing Systems Sales Market Share by Application (2021-2032)
  9. 5.3 Global Drugs of Abuse Testing Systems Revenue by Application
  10. 5.3.1 Global Drugs of Abuse Testing Systems Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Drugs of Abuse Testing Systems Revenue by Application (2021-2032)
  12. 5.3.3 Global Drugs of Abuse Testing Systems Revenue Market Share by Application (2021-2032)
6 Global Drugs of Abuse Testing Systems Sales by Region
  1. 6.1 Global Drugs of Abuse Testing Systems Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Drugs of Abuse Testing Systems Sales by Region (2021-2032)
  3. 6.2.1 Global Drugs of Abuse Testing Systems Sales by Region (2021-2026)
  4. 6.2.2 Global Drugs of Abuse Testing Systems Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Drugs of Abuse Testing Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Drugs of Abuse Testing Systems Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Drugs of Abuse Testing Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Drugs of Abuse Testing Systems Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Drugs of Abuse Testing Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Drugs of Abuse Testing Systems Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Drugs of Abuse Testing Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Drugs of Abuse Testing Systems Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Drugs of Abuse Testing Systems Revenue by Region
  1. 7.1 Global Drugs of Abuse Testing Systems Revenue by Region
  2. 7.1.1 Global Drugs of Abuse Testing Systems Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Drugs of Abuse Testing Systems Revenue by Region (2021-2026)
  4. 7.1.3 Global Drugs of Abuse Testing Systems Revenue by Region (2027-2032)
  5. 7.1.4 Global Drugs of Abuse Testing Systems Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Drugs of Abuse Testing Systems Revenue (2021-2032)
  8. 7.2.2 North America Drugs of Abuse Testing Systems Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Drugs of Abuse Testing Systems Revenue (2021-2032)
  11. 7.3.2 Europe Drugs of Abuse Testing Systems Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Drugs of Abuse Testing Systems Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Drugs of Abuse Testing Systems Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Drugs of Abuse Testing Systems Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Drugs of Abuse Testing Systems Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Drugs of Abuse Testing Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Drugs of Abuse Testing Systems Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Thermo Fisher Scientific
  8. 8.2.1 Thermo Fisher Scientific Company Information
  9. 8.2.2 Thermo Fisher Scientific Business Overview
  10. 8.2.3 Thermo Fisher Scientific Drugs of Abuse Testing Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific Drugs of Abuse Testing Systems Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific Recent Developments
  13. 8.3 Roche
  14. 8.3.1 Roche Company Information
  15. 8.3.2 Roche Business Overview
  16. 8.3.3 Roche Drugs of Abuse Testing Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Roche Drugs of Abuse Testing Systems Product Portfolio
  18. 8.3.5 Roche Recent Developments
  19. 8.4 Wondfo Biotech
  20. 8.4.1 Wondfo Biotech Company Information
  21. 8.4.2 Wondfo Biotech Business Overview
  22. 8.4.3 Wondfo Biotech Drugs of Abuse Testing Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Wondfo Biotech Drugs of Abuse Testing Systems Product Portfolio
  24. 8.4.5 Wondfo Biotech Recent Developments
  25. 8.5 Siemens Healthineers
  26. 8.5.1 Siemens Healthineers Company Information
  27. 8.5.2 Siemens Healthineers Business Overview
  28. 8.5.3 Siemens Healthineers Drugs of Abuse Testing Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Siemens Healthineers Drugs of Abuse Testing Systems Product Portfolio
  30. 8.5.5 Siemens Healthineers Recent Developments
  31. 8.6 Randox Laboratories
  32. 8.6.1 Randox Laboratories Company Information
  33. 8.6.2 Randox Laboratories Business Overview
  34. 8.6.3 Randox Laboratories Drugs of Abuse Testing Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Randox Laboratories Drugs of Abuse Testing Systems Product Portfolio
  36. 8.6.5 Randox Laboratories Recent Developments
  37. 8.7 Orient Gene Biotech
  38. 8.7.1 Orient Gene Biotech Company Information
  39. 8.7.2 Orient Gene Biotech Business Overview
  40. 8.7.3 Orient Gene Biotech Drugs of Abuse Testing Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Orient Gene Biotech Drugs of Abuse Testing Systems Product Portfolio
  42. 8.7.5 Orient Gene Biotech Recent Developments
  43. 8.8 OraSure
  44. 8.8.1 OraSure Company Information
  45. 8.8.2 OraSure Business Overview
  46. 8.8.3 OraSure Drugs of Abuse Testing Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 OraSure Drugs of Abuse Testing Systems Product Portfolio
  48. 8.8.5 OraSure Recent Developments
  49. 8.9 Intec
  50. 8.9.1 Intec Company Information
  51. 8.9.2 Intec Business Overview
  52. 8.9.3 Intec Drugs of Abuse Testing Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Intec Drugs of Abuse Testing Systems Product Portfolio
  54. 8.9.5 Intec Recent Developments
  55. 8.10 Hangzhou Biotest
  56. 8.10.1 Hangzhou Biotest Company Information
  57. 8.10.2 Hangzhou Biotest Business Overview
  58. 8.10.3 Hangzhou Biotest Drugs of Abuse Testing Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hangzhou Biotest Drugs of Abuse Testing Systems Product Portfolio
  60. 8.10.5 Hangzhou Biotest Recent Developments
  61. 8.11 Drager
  62. 8.11.1 Drager Company Information
  63. 8.11.2 Drager Business Overview
  64. 8.11.3 Drager Drugs of Abuse Testing Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Drager Drugs of Abuse Testing Systems Product Portfolio
  66. 8.11.5 Drager Recent Developments
  67. 8.12 Assure Tech (Hangzhou) Co
  68. 8.12.1 Assure Tech (Hangzhou) Co Company Information
  69. 8.12.2 Assure Tech (Hangzhou) Co Business Overview
  70. 8.12.3 Assure Tech (Hangzhou) Co Drugs of Abuse Testing Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Assure Tech (Hangzhou) Co Drugs of Abuse Testing Systems Product Portfolio
  72. 8.12.5 Assure Tech (Hangzhou) Co Recent Developments
  73. 8.13 Aotai Bio
  74. 8.13.1 Aotai Bio Company Information
  75. 8.13.2 Aotai Bio Business Overview
  76. 8.13.3 Aotai Bio Drugs of Abuse Testing Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Aotai Bio Drugs of Abuse Testing Systems Product Portfolio
  78. 8.13.5 Aotai Bio Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Drugs of Abuse Testing Systems Value Chain Analysis
  2. 9.1.1 Drugs of Abuse Testing Systems Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Drugs of Abuse Testing Systems Production Mode & Process
  6. 9.2 Drugs of Abuse Testing Systems Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Drugs of Abuse Testing Systems Distributors
  9. 9.2.3 Drugs of Abuse Testing Systems Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst